The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Urgent hypertension as a biomarker for bevacizumab in the curative setting.
 
Nawal Kassem
No Relationships to Disclose
 
Fei Shen
No Relationships to Disclose
 
Guanglong Jiang
No Relationships to Disclose
 
Laura Gardner
No Relationships to Disclose
 
Santosh Philips
No Relationships to Disclose
 
Anne M. O'Neill
No Relationships to Disclose
 
Kathy D. Miller
No Relationships to Disclose
 
Thomas Suter
No Relationships to Disclose
 
David A. Cameron
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis
 
George W. Sledge
Leadership - Syndax
Stock and Other Ownership Interests - Syndax
Honoraria - Symphony Evolution
Consulting or Advisory Role - Coherus Biosciences; Peregrine Pharmaceuticals; Radius Health; Symphony Evolution; Taiho Pharmaceutical
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Radius Health; Taiho Pharmaceutical
 
Bryan Paul Schneider
No Relationships to Disclose